Mutual of America Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Mutual of America Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.41M	Buy	+29,144	New	+$2.93M	0.03%	577

Other funds holding MIRM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Mutual of America Capital Management's MIRM Position: Q2 2026 in Review

Mutual of America Capital Management opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 29,144 shares worth $3.41M. The stake represents 0.03% of the portfolio and ranks #577 among its holdings.

149 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

Mutual of America Capital Management held 29,144 shares of Mirum Pharmaceuticals worth $3.41M as of Q2 2026.
Mirum Pharmaceuticals was a new Mutual of America Capital Management position in Q2 2026.
Mirum Pharmaceuticals made up 0.03% of Mutual of America Capital Management's portfolio in Q2 2026, its #577 holding.
149 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.